Skip to content

Phenotype normalization

Phenotype normalization is a critical preprocessing step in GWAS to ensure valid statistical inference, numerical stability, and comparability across cohorts.

On this page

Raw measures

Definition

The phenotype is analyzed in its original measurement scale:

\[ Y_i = \text{observed phenotype for individual } i \]

When appropriate - Binary traits (case–control) - Approximately normally distributed quantitative traits

Pros - Preserves biological units and interpretability

Cons - Sensitive to skewness and outliers

Residual (covariate and medication adjusted)

Definition

The phenotype is adjusted for covariates and medication effects using regression:

\[Y_i = \alpha + \mathbf{C}_i^\top \gamma + \mathbf{M}_i^\top \delta + \varepsilon_i\]
\[ Y_i^{\text{resid}} = \hat{\varepsilon}_i \]

where

  • \(\mathbf{C}_i\): age, sex, PCs, batch, center
  • \(\mathbf{M}_i\): medication indicators, dosage, or drug class

Medication adjustment strategies - Indicator-based covariate (most common) - Dosage or drug-class covariates - Pre-correction (phenotype shifting, e.g. +10 mmHg for BP) - Exclusion of medicated individuals (not recommended)

Pros - Removes systematic non-genetic effects - Improves power and reduces bias

Cons - Residuals may still be non-normal

Z score

Definition

Standardization to zero mean and unit variance:

\[ Z_i = \frac{Y_i - \mu_Y}{\sigma_Y} \quad \text{or} \quad Z_i = \frac{Y_i^{\text{resid}} - \mu_{\text{resid}}}{\sigma_{\text{resid}}} \]

Pros - Comparable effect sizes across cohorts - Stable regression behavior

Cons - Does not correct skewness - Sensitive to outliers

Rank-based inverse normal transformation (INT)

Definition

Transforms phenotype ranks to a standard normal distribution:

\[ Y_i^{\text{INT}} = \Phi^{-1}\left( \frac{r_i - c}{n + 1 - 2c} \right) \]

where

  • \(r_i\): rank of individual \(i\)
  • \(c = 3/8\) (Blom's transformation, commonly used; \(c = 0.5\) is also used in Rankit transformation)

Pros - Enforces normality - Robust to outliers - Controls type-I error

Cons - Effect sizes lose original scale - Alters genetic architecture

  • Raw → GWAS (binary traits)
  • Residual → Z (well-behaved quantitative traits)
  • Residual → INT (highly skewed traits)
  • Medication correction → Residual → Z / INT (clinical traits)

References